Table 3.

Correlation coefficients between ACR core set measures and DAS28 determined at 12 to 24 week intervals and means of these variables over the 96 week period, and the increase in total Sharp score over 96 weeks.

Initial12 Weeks24 Weeks48 Weeks72 Weeks96 WeeksMean#
CRP0.292*0.477***0.562***0.521***0.479***0.2270.573***
ESR0.2350.491***0.402**0.350*0.0550.0280.380**
MHAQ0.1380.1830.2100.2500.2460.0050.272
Patients’ pain estimation0.1630.521***0.428**0.405**0.472**0.0250.531***
Patients’ global assessment††0.1520.500***0.470***0.382**0.563***0.0490.554***
Swollen joint count0.279*0.434**0.411**0.518***0.2660.2140.523***
Tender joint count0.0850.2570.1490.2020.2400.0310.275*
Physicians’ global assessment†††0.2530.449***0.478***0.453***0.419**0.1010.524***
DAS28-(CRP)0.384**0.592***0.610***0.538***0.447**0.293*0.618***
  • Patients’ estimation of pain on visual analog scale (VAS).

  • †† Patients’ global assessment of disease activity on VAS.

  • ††† Physicians’ global assessment of disease activity on VAS.

  • * p < 0.05;

  • ** p < 0.01;

  • *** p < 0.001.

  • # Mean of values determined every 12 weeks over 96 week treatment period.